文献速递肾小球疾病遗传性与小管间质肾病

人类层粘连蛋白β2突变在Alport综合征模型中的致病性

Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome.
PubMed 文献 · J Am Soc Nephrol · 2017-12-20

本研究探讨Pierson综合征相关LAMB2-S80R错义突变(位于LN结构域)的致病性。生化数据显示该突变损害层粘连蛋白聚合。在Col4a3-/-小鼠中表达LAMB2-S83R加速肾衰竭进展,在Col4a5+/-雌鼠中增加蛋白尿,表明该突变可遗传修饰Alport表型。

要点

  • LAMB2-S80R突变损害层粘连蛋白聚合,单独不足以致病。
  • LAMB2-S83R加重Col4a3-/-小鼠肾衰竭进展。
  • LAMB2-S83R增加Col4a5+/-雌鼠蛋白尿。

核心结论

  • LAMB2-S80R具有致病性,且首次证明另一种GBM成分变异可遗传修饰Alport表型。

研究设计与样本

  • 生化实验分析LAMB2-S80R对层粘连蛋白聚合的影响,并在基因修饰小鼠中表达对应突变LAMB2-S83R。
  • 使用Col4a3-/-小鼠(常染色体隐性Alport综合征模型)和Col4a5+/-雌鼠(X连锁Alport综合征轻型模型)。

主要发现

  • 生化数据显示LAMB2-S80R损害层粘连蛋白聚合。
  • LAMB2-S83R单独表达不致病。
  • LAMB2-S83R显著加速Col4a3-/-小鼠肾衰竭进展。
  • LAMB2-S83R增加Col4a5+/-雌鼠蛋白尿。

临床怎么用

  • 提示LAMB2等GBM成分变异可能解释Alport综合征发病年龄和严重程度的差异,即使同一COL4突变家系成员。

局限性

  • 研究结果揭示利用模式生物研究疑似致病人类基因变异的复杂性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pierson syndrome is a congenital nephrotic syndrome with eye and neurologic defects caused by mutations in laminin β2 (LAMB2), a major component of the glomerular basement membrane (GBM). Pathogenic missense mutations in human LAMB2 cluster in or near the laminin amino-terminal (LN) domain, a domain required for extracellular polymerization of laminin trimers and basement membrane scaffolding. Here, we investigated an LN domain missense mutation, LAMB2-S80R, which was discovered in a patient with Pierson syndrome and unusually late onset of proteinuria. Biochemical data indicated that this mutation impairs laminin polymerization, which we hypothesized to be the cause of the patient's nephrotic syndrome. Testing this hypothesis in genetically altered mice showed that the corresponding amino acid change (LAMB2-S83R) alone is not pathogenic. However, expression of LAMB2-S83R significantly increased the rate of progression to kidney failure in a Col4a3-/- mouse model of autosomal recessive Alport syndrome and increased proteinuria in Col4a5+/- females that exhibit a mild form of X-linked Alport syndrome due to mosaic deposition of collagen α3α4α5(IV) in the GBM. Collectively, these data show the pathogenicity of LAMB2-S80R and provide the first evidence of genetic modification of Alport phenotypes by variation in another GBM component. This finding could help explain the wide range of Alport syndrome onset and severity observed in patients with Alport syndrome, even for family members who share the same COL4 mutation. Our results also show the complexities of using model organisms to investigate genetic variants suspected of being pathogenic in humans.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Funk SD, Bayer RH, Malone AF, et al. Pathogenicity of a Human Laminin β2 Mutation Revealed in Models of Alport Syndrome. J Am Soc Nephrol. 2017. PMID: 29263159. doi:10.1681/ASN.2017090997

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。